Despite the overall increase in cash turnover of homeopathic medicines in Russia, natural sales volumes are declining in most regions, according to data from the analytical company RNC Pharma. The market’s steady growth is driven by active consumption in 16 Russian regions, including the Chechen Republic and the Republic of Dagestan.
The Russian homeopathic market continues to display contradictory dynamics: in monetary terms, there is consistent growth, but in physical volume, most regions are experiencing declines. In the first half of 2025, retail sales—including online—totaled 12.6 million packages worth 8.8 billion rubles, representing a 13.4% increase in rubles and a 1.9% rise in packages compared to the same period in 2024.
Regional analysis reveals a clear trend: demand for homeopathy in physical units declined in most federal subjects, including Moscow (-1.9%) and St. Petersburg (-0.2%). Growth in package sales was registered only in 16 regions, with the Chechen Republic (+20.8%), the Republic of Dagestan (+11.2%), and the Nenets Autonomous Okrug (+11.2%) emerging as leaders. These territories offset the overall decline, driving positive market dynamics.
The market remains highly concentrated: three companies—Heel (Germany), Materia Medica (Russia), and Boiron (France)—control more than 84% of the revenue turnover. Heel leads with a 38.4% share, with its key brand Traumel. Materia Medica holds 28.1%, primarily through Anaferon, while Boiron accounts for 17.8% with Homeovox.
The pharmaceutical market offers a range of 454 trademarks and 623 SKUs from 32 manufacturers. Heel has 55 brands, while Edas International Corporation LLC owns 63, with Passambra Edas-306 as its leading product. Although most of the top 10 companies report increases in monetary turnover, many see a decline in physical volume.
Earlier reports indicated that, despite the Russian Academy of Sciences recognizing homeopathy as a pseudoscience, nearly half of Russian doctors continue to prescribe homeopathic medicines—based on their own beliefs, clinical recommendations, or patient requests. Opinions among physicians about including homeopathy in official documents remain divided: 51% oppose it, while about a third support its inclusion, citing psychological comfort for patients and doctors.
